Source: Business Wire

Press Release: SynBioBeta : Twist Bioscience to Present at SynBioBeta 2019

SAN FRANCISCO--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced several presentations at SynBioBeta 2019, the leading industry conference bringing together biological engineers, investors, innovators and entrepreneurs to build a better world with biology, to be held October 1-3 in San Francisco, California. Twist's presence at the meeting includes:

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
John Cumbers's photo - Founder & CEO of SynBioBeta

Founder & CEO

John Cumbers

CEO Approval Rating

70/100